Hyderabad, September 19
The Strategic Advisory Group of Experts on Immunisation (SAGE) of the World Health Organisation would be meeting on October 6 to make its recommendations on Bharat Biotech’s Covid-19 vaccine Covaxin on emergency use listing.
Bharat Biotech is expected to give a presentation on the vaccine’s safety and efficacy data of clinical trials (phase 1-3 trial results and post marketing) and risk management plans and other implementation considerations, according to the SAGE draft agenda.
SAGE is authorised with advising the WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions. Hanna Nohynek, member of SAGE, will be presenting a draft recommendation for the vaccine and the session will make its recommendations. The session will thoroughly discuss the clinical data on Covaxin from phase 1, 2, 3 trials and post marketing studies on safety, immunogenicity, efficacy and effectiveness. — PTI
The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet to be confirmed, according to the update available on the WHO website.
Action follows in the wake of the Tribune expose about Nihan...
Top court wants SIT to record statements of more witnesses b...
Second UN Sustainable Transport Conference was hosted in Bei...
The Deputy CM was reacting to Amarinder’s intentions of anno...